Navigation Links
Deflazacort in Duchenne Muscular Dystrophy
Date:3/24/2016

LONDON, March 24, 2016 /PRNewswire/ --

US Neurology, the peer-reviewed journal, has published an article summarizing the benefits and risks of deflazacort in Duchenne muscular dystrophy.

     (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO)

Duchenne muscular dystrophy (DMD) is a devastating disorder that is the most common and severe form of childhood onset muscular dystrophy. While guidelines exist that promote a multidisciplinary approach to treatment of DMD, surveys have identified inconsistent adherence to the recommendations. This is particularly highlighted by the variability in the prescriptive habits of corticosteroids, which have a long history of literature supporting their use in DMD. Relatively recent publications have uncovered differences between countries in the prescription patterns of steroid regimens. Currently, treatment recommendations lack comparative data on the efficacy and safety of alternative dosing regimens of corticosteroids. New research is being conducted to help understand the benefits and risks of the most commonly used glucocorticoid regimens in DMD. Deflazacort is a glucocorticoid corticosteroid that is currently seeking approval in the U.S. This article summarizes the relevant published literature on deflazacort to help inform DMD-treating physicians on its impact on the disease.

The full peer-reviewed, open-access article is available here:

href="http://doi.org/10.17925/USN.2016.12.01.17" rel="nofollow">http://doi.org/10.17925/USN.2016.12.01.12

Note to the Editor

touchNEUROLOGY (a division of Touch Medical Media) publishes US Neurology, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of neurology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.

http://www.touchNEUROLOGY.com

For inquires please contact:
Carla Denaro - Managing Editor
+44 (0) 207 193 6093
managingeditor@touchmedicalmedia.com

Providing practical opinion to support best practice for busy healthcare professionals.



'/>"/>
SOURCE Touch Medical Media
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. DART Therapeutics Initiates Study of HT-100 For Duchenne Muscular Dystrophy
2. New Evidence Published in Muscle and Nerve on Measuring 6-Minute Walk Distance in Duchenne Muscular Dystrophy
3. PPMD to Lead Duchenne Community in Developing Draft Guidance to Accelerate Drug Development and FDA Review
4. PTC Therapeutics Completes Enrollment of Landmark Trial in Duchenne Muscular Dystrophy
5. Expected Launch of First Disease-Modifying Therapies Through 2023 Will Revolutionize Treatment of Duchenne Muscular Dystrophy
6. ARMGO Pharma and Servier Announce Advancement of Rycal ARM210/S48168 into Clinical Stage Program Targeting Duchenne Muscular Dystrophy
7. Parent Project Muscular Dystrophy and Foundation to Eradicate Duchenne Award $1 Million Grant to ReveraGen BioPharma
8. EspeRares Investigational Compound Rimeporide Receives European Orphan Drug Designation in Duchenne Muscular Dystrophy
9. Global Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Market 2015 - Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation
10. Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation
11. Global Duchenne Muscular Dystrophy Drugs Market 2015-2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
(Date:8/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... September 11, 2017, in New York . ... is scheduled to present at 11:05 a.m. Eastern Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one ... 10, 2017. About ...
Breaking Medicine Technology:
(Date:9/24/2017)... Caicos Islands, BWI (PRWEB) , ... September 24, 2017 , ... ... #1 rated resort on TripAdvisor and one of Provo's premier boutique resorts, is planning ... structural damage to the resort after devastating Hurricanes Irma and more recently Hurricane Maria, ...
(Date:9/24/2017)... (PRWEB) , ... September 24, 2017 , ... In “Sky and I”, a young boy was walking home and feeling ... friend who tells him otherwise. The new friend says he can do whatever he wants ... special and good enough just the way he is. God created him with special talents ...
(Date:9/23/2017)... Los Angeles, California (PRWEB) , ... September 23, ... ... Chicago Tribune discusses the behavioral approach to fighting obesity of Robert Kushner, director ... holistic approach to weight loss and promoting healthier habits, the article notes that ...
(Date:9/22/2017)... ... September 22, 2017 , ... MEDIA OPPORTUNITY: , Save Our Hospital - ... on why they are rallying against Mayo Clinic. Specifically, media can talk to steering ... Noseworthy’s (CEO) decision to close the Albert Lea hospital. , The rally aims to ...
(Date:9/22/2017)... ... September 22, 2017 , ... Fenwick Agency of Plano, TX has announced the ... part of the nationally recognized ‘Agents of Change’ movement. The agency pledges to select ... leaders to seek out those who most need help. Their hope is to bring ...
Breaking Medicine News(10 mins):